Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech IPO market slowdown—will it continue into 2017? – FierceBiotech


FierceBiotech

Biotech IPO market slowdown—will it continue into 2017?
FierceBiotech
This year will not go down as a classic for biotech IPOs; in fact, it’s been pretty dismal, with a report by Renaissance Capital out in the summer showing that almost all of the biotech IPOs that priced since the first quarter have broken issue, and

Search